Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Sio Gene Therapies Inc. (SIOX) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2022-12-31.
| Income Statement Financials | |
-- |
|
$-4.02M |
|
-- |
|
-- |
|
$4.48M |
|
$-4.48M |
|
$0.46M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.48M |
|
$-4.48M |
|
73.97M |
|
73.97M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$47.27M |
|
-- |
|
-- |
|
$47.27M |
|
$2.15M |
|
-- |
|
-- |
|
$2.15M |
|
$45.12M |
|
$45.12M |
|
$45.12M |
|
73.97M |
|
| Cash Flow Statement Financials | |
$-18.69M |
|
$-0.10M |
|
-- |
|
$64.91M |
|
$46.13M |
|
$-18.79M |
|
$0.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.97 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.91% |
|
-8.91% |
|
-8.50% |
|
-8.91% |
|
$0.61 |
|
$-0.25 |
|
$-0.25 |
|